<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-145849</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Laser and ranibuzumab combination for retinal vasoproliferative tumor's management</dc:title>
<dc:description xml:lang="en">Case report: A 34 year-old man presented with progressive visual loss in his right eye. Ocular fundus showed a vasoproliferative tumor in the peripheral retina with an associated epiretinal macular membrane. Angiography showed a rapid filling of tumor vessels. The treatment consisted of laser photocoagulation and a single injection of intravitreal ranibizumab. After 8 weeks, there was a residual area of fibrosis, the posterior hyaloid was detached, and the epiretinal membrane disappeared. Visual acuity returned to 20/25. Discussion: Laser photocoagulation and intravitreal ranibizumab combination could be useful for vasoproliferative tumors (AU)</dc:description>
<dc:creator>Fernández-Martínez, C</dc:creator>
<dc:creator>Martínez-Toldos, JJ</dc:creator>
<dc:creator>Hernández-Artola, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Varón de 34 años que presentó pérdida progresiva de visión en el ojo derecho. Se objetivó un tumor vasoproliferativo en la retina periférica con membrana epimacular asociada. La angiografía mostró un rápido llenado de los vasos tumorales. Se trató con fotocoagulación láser más ranibizumab intravítreo. Tras 8 semanas se evidenció la fibrosis de la lesión, el desprendimiento de la hialoides posterior y la desaparición de la membrana. La agudeza visual volvió a 20/25. Discusión: La combinación de fotocoagulación y ranibizumab intravítreo podría ser útil en el tratamiento de este tumor (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;90(12): 593-596, dic. 2015. ilus</dc:source>
<dc:identifier>ibc-145849</dc:identifier>
<dc:title xml:lang="es">Combinación de láser y ranibizumab en el manejo del tumor retiniano vasoproliferativo</dc:title>
<dc:subject>^d30674^s22039</dc:subject>
<dc:subject>^d24866^s29166</dc:subject>
<dc:subject>^d24366^s22022</dc:subject>
<dc:subject>^d8204^s22074</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8204^s22045</dc:subject>
<dc:subject>^d8204^s22039</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24866^s22067</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d33346^s22075</dc:subject>
<dc:subject>^d3162^s22045</dc:subject>
<dc:subject>^d30674^s22074</dc:subject>
<dc:subject>^d33346^s29166</dc:subject>
<dc:subject>^d30674^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201512</dc:date>
</metadata>
</record>
</ibecs-document>
